A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma

Authors: Looka, Andrew ¹, Qualls, David A. ^{1, ∗}, Matthews, Daniel ¹, Redd, Robert A. ², Sakellis, Christopher ³, Duffy, Caitlyn ¹, Dela Cruz, Jamie ¹, Saucier, Anna ¹, Armand, Philippe ¹, Crombie, Jennifer L. ¹, Fisher, David C. ¹, Jacobsen, Eric D. ¹, Kim, Austin I. ¹, LaCasce, Ann S. ¹, Merryman, Reid W. ¹, Parry, Erin M. ¹, Jacobson, Caron A. ¹

Source: In Blood Advances 11 February 2025 9(3):455-462

Single-cell dynamics of breakthrough toxicities after anakinra prophylaxis for axicabtagene ciloleucel in lymphoma

Authors: Frigault, Matthew J. ^{1, 2}, Yao, Ning ³, Berger, Trisha R. ¹, Wehrli, Marc ^{1, 2}, Gallagher, Kathleen M. E. ^{1, 2}, Horick, Nora ^{1, 2}, Graham, Charlotte E. ^{1, 2}, Jacobson, Caron A. ^{2, 4}, Chen, Yi-Bin ^{1, 2}, Leick, Mark B. ^{1, 2}, DeFilipp, Zachariah ^{1, 2}, El-Jawahri, Areej R. ^{1, 2}, Johnson, P. Connor ^{1, 2}, Dolaher, Maria ¹, Katsis, Katelin ¹, Kim, Austin I. ^{2, 4}, Crombie, Jennifer ^{2, 4}, Merryman, Reid W. ^{2, 4}, Cook, Daniella ¹, Trailor, Michael ¹, Cho, Hana ¹, Jeffrey, Richard, III ¹, Shen, Rhine ⁵, Filosto, Simone ⁵, Nater, Jenny ⁵, Getz, Gad ^{2, 3}, Haradhvala, Nicholas J. ³, Maus, Marcela V. ^{1, 2, 3, ∗}

Source: In Blood Advances January 2025

Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: primary analysis of the ELM-1 study

Authors: Topp, Max S. ^{1, ∗}, Matasar, Matthew ², Allan, John N. ³, Ansell, Stephen M. ⁴, Barnes, Jeffrey A. ⁵, Arnason, Jon E. ⁶, Michot, Jean-Marie ⁷, Goldschmidt, Neta ⁸, O’Brien, Susan M. ⁹, Abadi, Uri ^{10, 11}, Avivi, Irit ¹², Cheng, Yuan ¹³, Flink, Dina M. ¹³, Zhu, Min ¹³, Brouwer-Visser, Jurriaan ¹³, Chaudhry, Aafia ¹³, Mohamed, Hesham ¹³, Ambati, Srikanth ¹³, Crombie, Jennifer L. ¹⁴

Source: In Blood December 2024

Real-world outcomes with novel therapies in relapsed/refractory diffuse large B-cell lymphoma.

Authors: Crombie, Jennifer L.¹ (AUTHOR) Jennifer_crombie@dfci.harvard.edu, Jun, Monika² (AUTHOR), Wang, Tongsheng² (AUTHOR), Mutebi, Alex² (AUTHOR), Wang, Anthony³ (AUTHOR), Chhibber, Anindit² (AUTHOR), Kamalakar, Rajesh³ (AUTHOR), Ukropec, Jon² (AUTHOR), Blaedel, Julie² (AUTHOR), Kalsekar, Anupama² (AUTHOR)

Source: Leukemia & Lymphoma. Nov2024, Vol. 65 Issue 11, p1623-1633. 11p.

Subject Terms: *ELECTRONIC health records, *CHIMERIC antigen receptors, *NON-Hodgkin's lymphoma, *OVERALL survival, *DISEASE relapse

Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL

Authors: Ahn, Inhye E., Brander, Danielle M., Ren, Yue, Zhou, Yinglu, Tyekucheva, Svitlana, Walker, Heather A., Black, Robert, Montegaard, Josie, Alencar, Alvaro, Shune, Leyla, Omaira, Mohammad, Jacobson, Caron A., Armand, Philippe, Ng, Samuel Y., Crombie, Jennifer, Fisher, David C., LaCasce, Ann S., Arnason, Jon, Hochberg, Ephraim P., Takvorian, Ronald W., Abramson, Jeremy S., Brown, Jennifer R., Davids, Matthew S.

Source: In Blood Advances 27 February 2024 8(4):832-841

Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation

Authors: Merryman, Reid W., Redd, Robert A., Taranto, Eleanor, Ahmed, Gulrayz, Jeter, Erin, McHugh, Kristin M., Brown, Jennifer R., Crombie, Jennifer L., Davids, Matthew S., Fisher, David C., Freedman, Arnold S., Jacobsen, Eric, Jacobson, Caron A., Kim, Austin I., LaCasce, Ann S., Ng, Samuel Y., Odejide, Oreofe O., Parry, Erin M., Jacene, Heather, Park, Hyesun, Dahi, Parastoo B., Nieto, Yago, Joyce, Robin M., Chen, Yi-Bin, Shipp, Margaret A., Herrera, Alex F., Armand, Philippe

Source: In Blood Advances 12 September 2023 7(17):4748-4759

A multicenter, retrospective study of accelerated venetoclax ramp‐up in patients with relapsed/refractory chronic lymphocytic leukemia

Authors: Davids, Matthew S., Shadman, Mazyar, Parikh, Sameer A., Ujjani, Chaitra, Crombie, Jennifer L., Jiang, Dingfeng, Llamas, Cynthia, Feng, Dai, Lamanna, Nicole

Source: American journal of hematology. 97(3):E105-E109

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100139958953.0x000001&indx=1&recIds=ETOCvdc_100139958953.0x000001

Odronextamab, a human CD20×CD3 bispecific antibody in patients with CD20-positive B-cell malignancies (ELM-1): results from the relapsed or refractory non-Hodgkin lymphoma cohort in a single-arm, multicentre, phase 1 trial

Authors: Bannerji, Rajat, Arnason, Jon E, Advani, Ranjana H, Brown, Jennifer R, Allan, John N, Ansell, Stephen M, Barnes, Jeffrey A, O'Brien, Susan M, Chávez, Julio C, Duell, Johannes, Rosenwald, Andreas, Crombie, Jennifer L, Ufkin, Melanie, Li, Jingjin, Zhu, Min, Ambati, Srikanth R, Chaudhry, Aafia, Lowy, Israel, Topp, Max S

Source: Lancet.Haematology. 9(5):e327-e339

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100183247417.0x000001&indx=1&recIds=ETOCvdc_100183247417.0x000001

Prognostic value of minimal residual disease among patients with classical Hodgkin lymphoma undergoing autologous stem cell transplantation

Authors: Taranto, Eleanor, Redd, Robert, Jeter, Erin, McHugh, Kristin, Crombie, Jennifer L., Fisher, David C., Jacobsen, Eric, Jacobson, Caron A., Kim, Austin I., LaCasce, Ann S., Odejide, Oreofe O., Dahi, Parastoo B., Nieto, Yago, Joyce, Robin M., Chen, Yi-Bin, Bonjoc, Kimberley-Jane C., Chaudhry, Ammar, Herrera, Alex F., Armand, Philippe, Merryman, Reid W.

Source: Leukemia & lymphoma. 63(12):2912-2917

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173039611.0x000001&indx=1&recIds=ETOCvdc_100173039611.0x000001

Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.

Authors: Davids, Matthew S., Ryan, Christine E., Lampson, Benjamin L., Ren, Yue, Tyekucheva, Svitlana, Fernandes, Stacey M., Crombie, Jennifer L., Kim, Austin I., Weinstock, Matthew, Montegaard, Josie, Walker, Heather A., Greenman, Claire, Patterson, Victoria, Jacobson, Caron A., LaCasce, Ann S., Armand, Philippe, Fisher, David C., Lo, Steve, Olszewski, Adam J., Arnason, Jon E.

Source: Journal of Clinical Oncology; 3/1/2025, Vol. 43 Issue 7, p788-799, 21p

A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapy

Authors: Gouni, Sushanth ^*, Rosenthal, Allison C. ^*, Crombie, Jennifer L., Ip, Andrew, Kamdar, Manali K., Hess, Brian, Feng, Lei, Watson, Grace, Ayers, Amy, Neelapu, Sattva S., Khurana, Arushi, Lin, Yi, Iqbal, Madiha, Merryman, Reid W., Strati, Paolo ^*

Source: In Blood Advances 10 May 2022 6(9):2757-2762

Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study

Authors: Davids, Matthew S ^*, Lampson, Benjamin L, Tyekucheva, Svitlana, Wang, Zixu, Lowney, Jessica C, Pazienza, Samantha, Montegaard, Josie, Patterson, Victoria, Weinstock, Matthew, Crombie, Jennifer L, Ng, Samuel Y, Kim, Austin I, Jacobson, Caron A, LaCasce, Ann S, Armand, Philippe, Arnason, Jon E, Fisher, David C, Brown, Jennifer R

Source: In The Lancet Oncology October 2021 22(10):1391-1402

The treatment of Burkitt lymphoma in adults

Authors: Crombie, Jennifer ^*, LaCasce, Ann ^{*, *}

Source: In Blood 11 February 2021 137(6):743-750

The future of antibody therapy in chronic lymphocytic leukemia

Authors: Crombie, Jennifer L., Brown, Jennifer R.

Source: Expert opinion on emerging drugs. 26(3):323-336

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100128335407.0x000001&indx=1&recIds=ETOCvdc_100128335407.0x000001

A prospective study of minimal residual disease in patients with diffuse large B-cell lymphoma using an Ig-NGS assay

Authors: Chase, Matthew L., Merryman, Reid, Fisher, David C., Jacobsen, Eric, LaCasce, Ann, Jacobson, Caron, Freedman, Arnold, Davids, Matthew S., Brown, Jennifer R., Jacob, Allison, Armand, Philippe, Crombie, Jennifer

Source: Leukemia & lymphoma. 62(2):478-481

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100114474022.0x000001&indx=1&recIds=ETOCvdc_100114474022.0x000001

Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy Recipients

Authors: Aleissa, Muneerah M., Little, Jessica S., Davey, Sonya, Saucier, Anna, Zhou, Guohai, Gonzalez-Bocco, Isabel H., Crombie, Jennifer L., Looka, Andrew, Baden, Lindsey R., Issa, Nicolas C., Hammond, Sarah P., Jacobson, Caron A., Sherman, Amy C.

Source: Transplantation and Cellular Therapy. 29(6):398.e1-398.e5

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100191075003.0x000001&indx=1&recIds=ETOCvdc_100191075003.0x000001

Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma

Authors: Merryman, Reid W. ^*, Edwin, Natasha, Redd, Robert, Bsat, Jad, Chase, Matthew, LaCasce, Ann, Freedman, Arnold, Jacobson, Caron, Fisher, David, Ng, Samuel, Crombie, Jennifer, Kim, Austin, Odejide, Oreofe, Davids, Matthew S., Brown, Jennifer R., Jacene, Heather, Cashen, Amanda, Bartlett, Nancy L., Mehta-Shah, Neha, Ghobadi, Armin, Kahl, Brad, Joyce, Robin, Armand, Philippe ^*, Jacobsen, Eric ^*

Source: In Blood Advances 10 March 2020 4(5):858-867

PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation

Authors: Frigault, Matthew J. ^*, Armand, Philippe ^*, Redd, Robert A., Jeter, Erin, Merryman, Reid W., Coleman, Kimberly C., Herrera, Alex F., Dahi, Parastoo, Nieto, Yago, LaCasce, Ann S., Fisher, David C., Ng, Samuel Y., Odejide, Oreife O., Freedman, Arnold S., Kim, Austin I., Crombie, Jennifer L., Jacobson, Caron A., Jacobsen, Eric D., Wong, Jeffrey L., Bsat, Jad, Patel, Sanjay S., Ritz, Jerome, Rodig, Scott J., Shipp, Margaret A., Chen, Yi-Bin, Joyce, Robin M.

Source: In Blood Advances 14 January 2020 4(1):122-126

Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and Treatment

Authors: Crombie, Jennifer L., Armand, Philippe

Source: In Surgical Oncology Clinics of North America January 2020 29(1):115-125

Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma

Authors: Frigault, Matthew J. ^*, Dietrich, Jorg, Martinez-Lage, Maria, Leick, Mark, Choi, Bryan D., DeFilipp, Zachariah, Chen, Yi-Bin, Abramson, Jeremy, Crombie, Jennifer, Armand, Philippe, Nayak, Lakshmi, Panzini, Chris, Riley, Lauren S., Gallagher, Kathleen, Maus, Marcela V.

Source: In Blood 12 September 2019 134(11):860-866